搜索结果: 46-60 共查到“医学 oncology”相关记录95条 . 查询时间(0.027 秒)
![](http://www.firstlight.cn/upload/imgfile/20161/15/201611513272156.jpg)
Professor William F. Regine,Department of Radiation Oncology at University of Maryland(图)
Department of Radiation Oncology at University of Maryland Professor pancreas/gastrointestinal cancers
2016/1/15
![](http://www.firstlight.cn/upload/imgfile/20161/15/20161151325731.jpg)
Professor Terez Shea-Donohue,Department of Radiation Oncology at University of Maryland(图)
Department of Radiation Oncology at University of Maryland Professor alterations in gastrointestinal function
2016/1/15
![](http://www.firstlight.cn/upload/imgfile/20161/15/2016115132352140.jpg)
Professor Mohan Suntharalingam,Department of Radiation Oncology at University of Maryland(图)
Department of Radiation Oncology at University of Maryland Professor the head & neck and esophagus
2016/1/15
![](http://www.firstlight.cn/upload/imgfile/20161/15/201611513200546.jpg)
Professor Byong Y. Yi,Department of Radiation Oncology at University of Maryland(图)
Department of Radiation Oncology at University of Maryland Professor Commissioned the Rapid Arc technology
2016/1/15
The many faces of preventative care in the practice of oncology
preventative care oncology setting
2015/4/8
Prevention in the oncology setting has traditionally focused on the progression of cancer, recurrence and development
of new cancers. Increasingly, the focus has moved to a more holistic view of pre...
In parallel with the rapid development of oncology in Australia, palliative and supportive care has evolved rapidly. The
sponsorship for such development was largely generated by oncology services i...
Cancer is a major health problem in Australia. As such, improving cancer outcomes is a priority. Traditionally, cancer
outcomes such as mortality, survival rates and local recurrence rates have domi...
Tissue banking and its role in clinical and biological advances in oncology
oncology biological advances
2015/4/8
Basic scientific and clinical translational progress in oncology has progressed at an exponential rate over the last 40
years. Much of this progress was germinated in the laboratory, where rigorous ...
Quality assurance is important for any medical procedure or intervention to ensure that patients receive management that is suited to their medical condition and that which has been described in textb...
Talking about taste: how do oncology clinicians discuss and document taste problems?
oncology clinicians discuss taste problems
2015/4/2
Taste changes are frequently reported by patients undergoing cancer treatment. Taste problems are difficult to assess
and treat in the clinical oncology setting. This two-part study aimed to determi...
Medical Oncology Group of Australia Cancer Achievement Award
Medical Oncology Group Australia Cancer Achievement Award
2015/4/2
Thank you to Medical Oncology Group of Australia (MOGA) and Novartis, and thank you to those people who nominated me for this award. It is a privilege and an honour to receive it, and I appreciate thi...
Medical OncOlOgy grOup Of australia cancer achievement award – cancer, then and nOw
ustralia cancer Medical OncOlOgy
2015/4/1
When I graduated in 1972, the most common cancer
in males was lung cancer, with cancer overall equally
distributed between men and women.1
In 1980, less than
half of all people diagnosed with ...
Medical Oncology Group of Australia/ Novartis Cancer Achievement Award
clinical training career values
2015/3/26
It was totally unexpected as I don’t feel that I have done
anything particularly special, but it is very gratifying to
receive such recognition from one’s peers and to be
included among the previou...
Overview: Geriatric oncology: a medical sub-specialty whose time has come
Geriatric oncology onco-geriatrics
2015/3/25
It is a truism that cancer is a disease of older people and
that as the population ages the incidence and
prevalence of cancer increases. Fifty per cent of cancers
occur in those over 65 years of a...
Medical Oncology Group of Australia, Pierre Fabre Cancer Achievement Award: Papillomavirus specific immunity as a means to prevent deaths from cervical cancer
Medical Oncology Group of Australia Pierre Fabre Cancer Achievement Award Papillomavirus specific immunity as a means to prevent deaths from cervical cancer
2015/3/24
Cervical cancer was shown by Professor Harald zur Hausen in the early 1980s to be initiated by infection of cervical epithelium with certain human papillomaviruses, now designated as “high risk” papil...